“Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified as Having Skin of Color: A Post Hoc Analysis of JADE COMPARE”, J of Skin, vol. 10, no. 2, p. s733, Mar. 2026, doi: 10.25251/8r6ert44.